TY - JOUR
T1 - P-84 Can a patient navigator increase quality of life in colorectal cancer patients?
T2 - The WeGuide trial
AU - Semedo, P.
AU - Motta, Gláucia Possas da
AU - Costa, A.
AU - Mansinho, A.
AU - Pissarra, A.
AU - Mansinho, A.
PY - 2022/6/1
Y1 - 2022/6/1
N2 - An estimated one-third of patients with cancer will experience clinically significant distress, manifesting as anxiety or depression that is associated with their diagnosis and treatment. This has been shown to negatively impact health outcomes and quality of life (QOL). Intrahospital processes are complex, involving a significant amount of paperwork and several stakeholders, creating overwhelming circuits which can add up to generating more anxiety. Patient navigators (PN) can help to overcome these barriers by helping in several dimensions: information management and mediation (organize clinical information, prepare appointments, engaging in patient-healthcare professional communication), healthcare education and self-care (clarifying doubts about the therapeutic process, encouraging adherence to therapy) and on emotional and spiritual support (mobilizing social and family support, self-help groups). On this basis, the investigators designed the WeGuide trial, with the primary objective of assessing the impact of a PN in the QOL of patients with colorectal (CRC) cancer and also the utility of a PN from the patient’s point of view.
AB - An estimated one-third of patients with cancer will experience clinically significant distress, manifesting as anxiety or depression that is associated with their diagnosis and treatment. This has been shown to negatively impact health outcomes and quality of life (QOL). Intrahospital processes are complex, involving a significant amount of paperwork and several stakeholders, creating overwhelming circuits which can add up to generating more anxiety. Patient navigators (PN) can help to overcome these barriers by helping in several dimensions: information management and mediation (organize clinical information, prepare appointments, engaging in patient-healthcare professional communication), healthcare education and self-care (clarifying doubts about the therapeutic process, encouraging adherence to therapy) and on emotional and spiritual support (mobilizing social and family support, self-help groups). On this basis, the investigators designed the WeGuide trial, with the primary objective of assessing the impact of a PN in the QOL of patients with colorectal (CRC) cancer and also the utility of a PN from the patient’s point of view.
U2 - 10.1016/j.annonc.2022.04.174
DO - 10.1016/j.annonc.2022.04.174
M3 - Article
SN - 0923-7534
VL - 33
SP - S278
JO - Annals of Oncology
JF - Annals of Oncology
IS - suppl. 4
ER -
